CWM
REGN icon

Circle Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Circle Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$761K Sell
1,221
-19
-2% -$12.9K 0.01% 175
2026
Q1 		$958K Buy
1,240
+15
+1% +$11.5K 0.01% 145
2025
Q4 		$946K Buy
1,225
+4
+0.3% +$2.72K 0.01% 139
2025
Q3 		$687K Buy
1,221
+331
+37% +$187K 0.01% 151
2025
Q2 		$467K Hold
890
– – 0.01% 173
2025
Q1 		$564K Hold
890
– – 0.01% 157
2024
Q4 		$634K Hold
890
– – 0.01% 150
2024
Q3 		$936K Hold
890
– – 0.02% 122
2024
Q2 		$935K Sell
890
-5
-0.6% -$4.85K 0.02% 101
2024
Q1 		$861K Hold
895
– – 0.02% 107
2023
Q4 		$786K Sell
895
-7
-0.8% -$5.76K 0.02% 103
2023
Q3 		$742K Buy
902
+257
+40% +$202K 0.02% 99
2023
Q2 		$463K Sell
645
-2
-0.3% -$1.54K 0.06% 107
2023
Q1 		$532K Buy
647
+2
+0.3% +$1.51K 0.08% 92
2022
Q4 		$465K Buy
645
+10
+2% +$7.38K 0.07% 101
2022
Q3 		$437K Sell
635
-10
-2% -$6.29K 0.07% 108
2022
Q2 		$381K Hold
645
– – 0.06% 122
2022
Q1 		$450K Hold
645
– – 0.06% 129
2021
Q4 		$407K Buy
+645
New +$397K 0.05% 137
2021
Q1 		– Sell
-3,675
Closed -$1.77M – 211
2020
Q4 		$1.77M Hold
3,675
– – 0.25% 44
2020
Q3 		$2.06M Sell
3,675
-8
-0.2% -$4.85K 0.34% 35
2020
Q2 		$2.3M Sell
3,683
-1,396
-27% -$792K 0.4% 34
2020
Q1 		$2.48M Sell
5,079
-239
-4% -$98.6K 0.48% 32
2019
Q4 		$2M Sell
5,318
-52
-1% -$17.5K 0.35% 34
2019
Q3 		$1.49M Sell
5,370
-50
-0.9% -$14.8K 0.32% 39
2019
Q2 		$1.7M Sell
5,420
-890
-14% -$296K 0.37% 33
2019
Q1 		$2.59M Buy
+6,310
New +$2.6M 0.58% 21

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Circle Wealth Management's REGN Position: Q2 2026 in Review

Circle Wealth Management reduced its Regeneron Pharmaceuticals (REGN) stake by 1.5% in Q2 2026, selling an estimated $12.9K and leaving 1,221 shares worth $761K. The position accounts for 0.01% of the portfolio, ranked #175.

Circle Wealth Management first reported a position in REGN in Q1 2019 and has held it in 27 quarters since. The position peaked at $2.59M in Q1 2019. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Circle Wealth Management held 1,221 shares of Regeneron Pharmaceuticals worth $761K as of Q2 2026.
  • Circle Wealth Management sold 19 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $12.9K.
  • Regeneron Pharmaceuticals made up 0.01% of Circle Wealth Management's portfolio in Q2 2026, its #175 holding.
  • Circle Wealth Management first reported a position in Regeneron Pharmaceuticals in Q1 2019 and has held it in 27 quarters since.
  • Circle Wealth Management's Regeneron Pharmaceuticals position peaked at $2.59M in Q1 2019.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Circle Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.